Hyderabad : Zeus Hygia Lifesciences has announced the launch of Metaberine®, a next-generation berberine formulation, in the Europe and US markets. Developed using its proprietary BioSOLVE Technology, the formulation is designed to address the long-standing limitations of conventional berberine by improving its absorption and effectiveness in the body. By enhancing how berberine is utilised, Metaberine® enables more efficient support for metabolic health, including blood sugar balance and healthy weight management.
As lifestyle-driven health concerns such as weight gain, insulin resistance, and metabolic imbalance continue to rise, there is growing demand for solutions that are both effective and practical for long-term use. Berberine has been widely recognised for its role in supporting glucose metabolism and insulin sensitivity. However, conventional forms have been limited by poor solubility, low absorption, and the need for higher doses.
Metaberine® has been developed to address these gaps by improving how berberine dissolves and is absorbed in the body. This allows it to deliver faster and more efficient metabolic support at lower doses, while also improving overall tolerability.
“Metaberine® focuses on improving delivery rather than increasing dosage,” said Dr. Arunkanth Krishnakumar, Co-founder and CEO, Zeus Hygia Lifesciences. “By enhancing absorption, it supports key metabolic pathways more efficiently, including those linked to blood sugar regulation, energy utilisation, and weight management.”
A key mechanism associated with Metaberine® is its role in supporting the GLP-1 pathway, which is linked to insulin response, appetite regulation, and glucose balance. By supporting this pathway, Metaberine® helps the body manage blood sugar levels more effectively, while also contributing to improved satiety and reduced cravings.
Regular use of Metaberine® may support improved insulin sensitivity, more stable glucose levels, better energy utilisation, and reduced metabolic fatigue. These combined effects contribute to healthier weight management outcomes and overall metabolic efficiency. Early data indicates improved plasma concentration and faster absorption timelines, supporting more immediate metabolic response.
Metaberine® is also being explored for its potential relevance in conditions such as PCOS, where insulin resistance and metabolic dysfunction are key underlying factors. By improving metabolic function, it may support better hormonal balance as part of a broader wellness approach.
Manufactured at Zeus Hygia’s certified facilities, Metaberine® is a plant-derived, clean-label ingredient that is vegan and non-GMO. It is designed for integration across a wide range of formats including capsules, powders, and functional formulations.
Metaberine® is being positioned for B2B partnerships across pharmaceutical, nutraceutical, and functional food sectors, enabling the development of next-generation products focused on metabolic health, blood sugar support, and healthy weight management.